ZERIA PHARMCEUTICAL CO., LTD. Logo

ZERIA PHARMCEUTICAL CO., LTD.

Develops and distributes prescription & consumer healthcare products in Europe and Asia.

4559 | T

Overview

Corporate Details

ISIN(s):
JP3428850006
LEI:
Country:
Japan
Address:
中央区日本橋小舟町10番11号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Zeria Pharmaceutical Co., Ltd. is a comprehensive healthcare company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company operates through two primary business segments: Ethical Pharmaceuticals (prescription drugs) and Consumer Healthcare (over-the-counter products). Its consumer product portfolio includes nutritional health drugs, remedies for gastrointestinal diseases, cold remedies, and ophthalmic solutions. Zeria actively expands its R&D pipeline by in-licensing and developing drugs with established sales records in overseas markets, distributing its products internationally across Europe and Asia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 02:00
Registration Form
確認書
Japanese 8.4 KB
2025-11-07 02:00
Interim Report
半期報告書-第72期(2025/04/01-2026/03/31)
Japanese 202.1 KB
2025-07-03 07:19
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2025-06-26 03:01
Regulatory News Service
内部統制報告書-第71期(2024/04/01-2025/03/31)
Japanese 24.9 KB
2025-06-26 03:00
Regulatory News Service
確認書
Japanese 8.4 KB
2025-06-26 03:00
Annual Report
有価証券報告書-第71期(2024/04/01-2025/03/31)
Japanese 1.5 MB
2024-11-08 02:01
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-11-08 02:00
Interim Report
半期報告書-第71期(2024/04/01-2025/03/31)
Japanese 204.2 KB
2024-07-03 03:44
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-06-27 07:11
Registration Form
確認書
Japanese 8.4 KB
2024-06-27 07:09
Governance Information
内部統制報告書-第70期(2023/04/01-2024/03/31)
Japanese 23.8 KB
2024-06-27 07:07
Annual Report
有価証券報告書-第70期(2023/04/01-2024/03/31)
Japanese 1.2 MB
2024-02-05 06:04
Quarterly Report
四半期報告書-第70期第3四半期(2023/10/01-2023/12/31)
Japanese 168.4 KB
2024-02-05 06:04
Report Publication Announcement
確認書
Japanese 8.3 KB
2023-11-06 07:10
Report Publication Announcement
確認書
Japanese 8.3 KB

Automate Your Workflow. Get a real-time feed of all ZERIA PHARMCEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ZERIA PHARMCEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ZERIA PHARMCEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Scienture Holdings, Inc. Logo
Develops and commercializes specialty drugs for unmet medical needs, focusing on CNS disorders.
United States of America
SCNX
Scilex Holding Co Logo
Develops and commercializes non-opioid products for acute and chronic pain management.
United States of America
SCLX
Scinai Immunotherapeutics Ltd. Logo
Dual-model biopharma: developing NanoAbs for I&I and offering CDMO services.
United States of America
SCNI
SciSparc Ltd. Logo
Developing cannabinoid-based therapies for central nervous system (CNS) disorders.
United States of America
SPRC
Develops high-purity stem cell therapies for incurable immunological and inflammatory diseases.
South Korea
298060
scPharmaceuticals Inc. Logo
Commercializes subcutaneous drug-device therapies for at-home cardiorenal care.
United States of America
SCPH
SCYNEXIS INC Logo
Developing novel anti-fungal therapies for difficult-to-treat, drug-resistant infections.
United States of America
SCYX
Seach Medical Group Ltd. Logo
Researches, cultivates, and produces certified medical cannabis oils and flowers for global markets.
Israel
SEMG
SEEGENE, INC. Logo
Develops multiplex qPCR diagnostic assays and automated systems for labs and healthcare worldwide.
South Korea
096530
SEIKAGAKU CORPORATION Logo
A research pharma company using glycoscience to develop drugs for orthopedic & ophthalmic diseases.
Japan
4548

Talk to a Data Expert

Have a question? We'll get back to you promptly.